Scheda di revisione: Understanding Edema and Heart Failure Mechanisms

📋 Course Outline

1. Ødem: årsaker og sykdomsmekanisme
2. Venstresidig hjertesvikt: symptomer og mekanismer
3. ACE-hemmere: virkning og effekt ved hjertesvikt
4. Ikke-medikamentell behandling ved kronisk hjertesvikt
5. KOLS: kronisk bronkitt og emfysem
6. Lungeemboli: årsaker og behandlingsprinsipper
7. Akutt nyresvikt: prerenal, renal og postrenal
8. Kronisk nyresvikt: avfallsstoffer, syre-base og elektrolytter
9. Diabetes mellitus type 1: autoimmun sykdom og insulin
10. Farmakologi: affinitet, absorpsjon, bivirkninger og CYP-variasjon

📖 1. Ødem: årsaker og sykdomsmekanisme

🔑 Key Concepts & Definitions

• Hydrostatisk ødem : Hydrostatisk ødem er ødem som skyldes økt trykk i kapillærene, slik at væske presses ut i vevet.
• Inflammatorisk eller allergisk ødem : Inflammatorisk eller allergisk ødem er ødem som skyldes økt lekkasje i kapillærveggen etter skade eller stoffpåvirkning.
• Lymfatisk ødem : Lymfatisk ødem er ødem som oppstår når lymfedrenasjen ikke klarer å fjerne proteinrik ekstracellulærvæske.
• Onkotisk ødem : Onkotisk ødem er ødem som skyldes lavt proteininnhold i blodet, som reduserer vannbinding og øker væskeutgang til vev.

📝 Essential Points

• Ved hydrostatisk ødem øker venetrykket bakover til kapillærene, og væske presses fra blodet til interstitiet.
• Økt blodstrøm inn i kapillærene kan øke kapillærtrykket og bidra til hydrostatisk ødem.
• Ved inflammatorisk/allergisk ødem øker permeabiliteten i kapillærveggen, slik at væske (og ofte mer innhold) lekker ut.
• Histamin er et eksempel på stoff som kan øke kapillærlekkasje og dermed gi inflammatorisk/allergisk ødem.
• Ved lymfatisk ødem dreneres ikke proteinrik ekstracellulærvæske tilbake til blodbanen, og væske blir stående i vevet.
• Ved onkotisk ødem gir lavere albumin lavere osmotisk “trekk” i blodet, så vann beveger seg ut i vevet for å utjevne konsentrasjoner (osmose).

💡 Memory Hook

Trykk (hydrostatisk) → væske ut; Lekkasjer (histamin) → væske ut; Lymfe svikter → protein blir igjen; Protein lavt (albumin) → osmose trekker vann ut.

📖 2. Venstresidig hjertesvikt: symptomer og mekanismer

🔑 Key Concepts & Definitions

• Venstresidig hjertesvikt : Venstresidig hjertesvikt er en tilstand der venstre hjertehalvdel ikke klarer å pumpe eller ta imot blod effektivt, slik at kroppens behov og lungesirkulasjonen påvirkes.
• Systolisk hjertesvikt : Systolisk hjertesvikt er svikt i venstre ventrikkel sin evne til å pumpe blod ut i kroppen, som gir utilstrekkelig blodforsyning.
• Diastolisk hjertesvikt : Diastolisk hjertesvikt er svikt i venstre ventrikkel sin evne til å fylle seg med blod, som gir problemer med mottak av blod fra lungekretsløpet.
• Lungestuvning : Lungestuvning er opphopning av blod i lungekretsløpet når venstre ventrikkel ikke klarer å føre blodet videre, noe som øker trykk og væskelekkasje.
• RAAS : RAAS er hormonstyrt regulering der økt aldosteron og ADH bidrar til væskeretensjon og økt sirkulerende volum ved hjertesvikt.

📝 Essential Points

• Venstresidig hjertesvikt gir symptomer fordi venstre ventrikkel ikke klarer å pumpe nok blod videre til systemkretsløpet.
• Ved lungestuvning hoper blodet seg opp i lungevenene fordi blodet fra lungekretsløpet ikke blir pumpet videre.
• Dyspné skyldes at lungene blir stivere når lungestuvningen reduserer elastisiteten og gjør pustingen tyngre.
• Økt trykk i lungekapillærene kan gi ødem i lungevevet via lekkasje av væske til luftveienes slimhinner.
• I alvorlige tilfeller kan lungeødem oppstå med væske i alveolene som blandes med luft og danner rosa skum fra nese og munn.
• Dyspné forverres ofte ved anstrengelse og når pasienten legger seg ned fordi blodtrykket i lungekretsløpet da øker.

💡 Memory Hook

Left heart can’t move blood forward → lung backlog → stiff lungs + capillary pressure → fluid leaks → dyspné and cough; RAAS adds extra fluid → edema.

📖 3. ACE-hemmere: virkning og effekt ved hjertesvikt

🔑 Key Concepts & Definitions

• ACE-hemmere : Drug class that blocks the angiotensin-converting enzyme to reduce formation of angiotensin II in the body.
• Angiotensin I : Hormone precursor that can be converted into angiotensin II by the angiotensin-converting enzyme (ACE).
• Angiotensin II : Vasoactive hormone that increases peripheral resistance and promotes aldosterone production, raising fluid retention.
• Aldosteron : Adrenal hormone that increases sodium and water reabsorption in renal tubules, contributing to fluid retention.

📝 Essential Points

• ACE-hemmere inhibit ACE, reducing conversion of angiotensin I to angiotensin II.
• Lower angiotensin II leads to reduced peripheral resistance, so blood pressure decreases.
• Reduced aldosteron production means less sodium and water reabsorption in the renal tubules.
• With less fluid retention, the heart faces a lower workload and improved circulatory conditions.
• In heart failure, fluid buildup increases cardiac load and can cause hydrostatic edema in dependent areas.

💡 Memory Hook

ACE → less Angiotensin II → less Aldosterone → less Na+/water retention → lower BP + less cardiac workload.

📖 4. Ikke-medikamentell behandling ved kronisk hjertesvikt

📝 Essential Points

• The provided source excerpt does not contain any content about non-drug treatment for chronic heart failure, so no exam-relevant facts can be extracted from it.
• If you share the course text for this specific topic (non-medication treatment in chronic heart failure), I can convert it into a full revision section with memorisable notions and key exam rules.

📖 5. KOLS: kronisk bronkitt og emfysem

🔑 Key Concepts & Definitions

• Kronisk bronkitt : A chronic airway disease where long-term inflammation leads to persistent mucus production and cough.
• Emphysema : A chronic lung condition where destruction of alveolar walls reduces elastic recoil and impairs gas exchange.
• Airflow limitation : A hallmark of COPD where narrowed airways and loss of elastic support cause reduced airflow, especially during exhalation.
• Ventilation–perfusion mismatch : A gas-exchange problem where uneven matching of airflow and blood flow lowers oxygen transfer and can worsen CO2 clearance.

📝 Essential Points

• KOLS is characterized by chronic airflow limitation that is typically progressive over time.
• Kronisk bronkitt mainly reflects chronic inflammation in the airways with increased mucus, contributing to obstruction.
• Emfysem mainly reflects alveolar wall destruction, which reduces elastic recoil and makes exhalation harder.
• Both conditions contribute to impaired gas exchange, often producing hypoxemia and dyspnea.
• Ventilation–perfusion mismatch is a key mechanism behind reduced oxygenation in COPD.

💡 Memory Hook

Bronchitis = mucus + cough; Emphysema = alveoli break + air trapping (harder exhale).

📖 6. Lungeemboli: årsaker og behandlingsprinsipper

🔑 Key Concepts & Definitions

• Lungeemboli : A lung condition where a blood clot blocks pulmonary arteries and reduces blood flow to lung tissue.
• Årsaker til lungeemboli : A set of mechanisms that lead to clot formation and travel to the lungs, most often from venous thrombosis.
• Behandlingsprinsipper ved lungeemboli : A treatment framework that aims to stop clot growth, prevent new clots, and restore adequate circulation.
• Venøs trombose : A clot formation in the deep veins that can dislodge and become an embolus to the pulmonary circulation.

📝 Essential Points

• A lungeemboli happens when an embolus lodges in pulmonary arteries and impairs perfusion of the lungs.
• The most common source is venous thrombosis, where a clot breaks off and travels through the bloodstream.
• Treatment principles focus on preventing further clot extension and new emboli while supporting oxygenation and circulation.
• If the patient is unstable, management prioritizes rapid restoration of effective circulation and urgent escalation of therapy.
• After the acute phase, prevention of recurrence is central to reduce the risk of additional embolic events.

💡 Memory Hook

Clot travels from deep veins → blocks lung arteries → perfusion drops → treat to stop clot growth and prevent recurrence.

📖 7. Akutt nyresvikt: prerenal, renal og postrenal

🔑 Key Concepts & Definitions

• Prerenal akutt nyresvikt : Prerenal akutt nyresvikt er nyresvikt der problemet skyldes redusert blodtilførsel til nyrene uten primær skade i nyrevevet.
• Renal akutt nyresvikt : Renal akutt nyresvikt er nyresvikt der selve nyrevevet er skadet, slik at filtreringen svikter.
• Postrenal akutt nyresvikt : Postrenal akutt nyresvikt er nyresvikt der urinavløpet er blokkert, slik at trykk og tilbakestrømning påvirker nyrefunksjonen.
• Klassifisering etter årsakssone : Klassifisering etter årsakssone er inndeling av akutt nyresvikt i prerenal, renal og postrenal basert på hvor i årsakskjeden problemet sitter.

📝 Essential Points

• Prerenal årsak handler om svikt i nyreperfusjon som gir redusert filtrering.
• Renal årsak handler om direkte skade på nyrevev som gir redusert nyrefunksjon.
• Postrenal årsak handler om obstruksjon i urinveiene som hindrer normal tømming.
• Symptomer og funn ved akutt nyresvikt styres av om problemet sitter før, i eller etter nyrene.
• Klassifiseringen brukes for å velge riktig utredning og behandling ved akutt nyresvikt.

💡 Memory Hook

Pre=Perfusjon (før nyrene), Renal=Nyrevev, Post=Post (etter nyrene) → blokk i avløpet.

📖 8. Kronisk nyresvikt: avfallsstoffer, syre-base og elektrolytter

🔑 Key Concepts & Definitions

• Uremic toxins : Uremic toxins are waste products that accumulate when kidney function declines and are linked to systemic symptoms.
• Metabolic acidosis : Metabolic acidosis is a blood acid–base disorder where acid accumulates or bicarbonate is lost, commonly in advanced kidney failure.
• Hyperkalemia : Hyperkalemia is an elevated blood potassium level caused by reduced renal excretion, increasing cardiac risk.
• Electrolyte imbalance : Electrolyte imbalance is a disturbance in ions such as sodium, potassium, calcium, and phosphate due to impaired kidney regulation.

📝 Essential Points

• Chronic kidney failure reduces clearance of nitrogenous waste, so avfallsstoffer build up in the body.
• Reduced acid excretion and impaired bicarbonate handling can shift blood toward lower pH (metabolic acidosis).
• Potassium elimination falls in chronic kidney failure, so hyperkalemia is a key electrolyte complication.
• Electrolytes can drift in multiple directions at once, so symptoms and ECG risk depend on which ion is affected.
• Acid–base and electrolyte problems often occur together in chronic kidney failure, so assessment should consider both systems.

💡 Memory Hook

Think “KIDNEY = K + acid control”: failing kidneys → K rises and acids accumulate.

📖 9. Diabetes mellitus type 1: autoimmun sykdom og insulin

🔑 Key Concepts & Definitions

• Type 1 diabetes : A chronic disease where the immune system damages insulin-producing cells, leading to insufficient insulin.
• Autoimmune disease : A condition where the immune system attacks the body’s own tissues instead of targeting pathogens.
• Insulin : A hormone that enables cells to take up glucose and helps regulate blood sugar levels.
• Oral drug absorption : The process by which a medicine taken by mouth moves from the gastrointestinal tract into the bloodstream.

📝 Essential Points

• Type 1 diabetes involves autoimmune destruction of insulin-producing cells, so insulin supply becomes inadequate.
• Insulin deficiency leads to impaired glucose regulation, which is the core problem behind hyperglycemia in type 1 diabetes.
• When taking oral medicines, food usually delays absorption because gastric emptying and transfer to the small intestine take longer.
• Some medicines must not be taken with certain foods because strong binding to food can prevent absorption from the intestine.
• Other medicines are absorbed better when taken with food, so timing with meals can change bioavailability.
• High-affinity binding means a drug strongly binds to its receptor on the target molecule, which can increase pharmacologic effect.

💡 Memory Hook

Type 1 = immune attack on insulin makers; food can delay absorption unless the drug needs/avoids specific meals.

📖 10. Farmakologi: affinitet, absorpsjon, bivirkninger og CYP-variasjon

🔑 Key Concepts & Definitions

• Drug–food binding : Drug–food binding is the tendency of a medicine to attach strongly to components in food, which can reduce or change intestinal uptake.
• Absorption rate : Absorption rate is how quickly a drug moves from the stomach into the small intestine and then into the body for systemic effect.
• Type A adverse effects : Type A adverse effects are dose-related reactions that are largely predictable from the drug’s known pharmacological action.
• CYP450 variation : CYP450 variation is genetic or functional differences in cytochrome P-450 enzymes that change how fast drugs are metabolized and how patients respond.

📝 Essential Points

• Absorption can be delayed when gastric emptying and transfer from stomach to small intestine take longer, increasing time before uptake.
• Some medicines must not be taken with food because strong binding to certain food types prevents adequate absorption from the intestine.
• Some medicines absorb better with food because food conditions increase uptake from the gut.
• Type A adverse effects occur in principle in anyone if the dose becomes high enough.
• Type A adverse effects are predictable from the drug’s mechanism and are dose-dependent.
• About 80% of adverse effects are classified as Type A in the provided guidance.

💡 Memory Hook

Type A = “Augmented” effect: dose ↑ → predictable pharmacology → adverse effects.

📊 Synthesis Tables

Types of edema and main mechanism

Edema type	Primary cause	Key mechanism
Hydrostatic	Increased capillary/venous pressure	Higher capillary pressure pushes fluid out into tissue
Inflammatory/allergic	Increased capillary wall leakage (e.g., histamine)	More fluid (often more contents) leaks through damaged/permeable capillary walls
Lymphatic	Reduced/absent lymph drainage	Protein-rich extracellular fluid is not drained back to blood
Oncotic	Low blood protein (albumin)	Lower water-binding in blood → osmotic shift of water to tissue (osmose)

⚠️ Common Pitfalls & Confusions

1. Mixing up hydrostatic vs oncotic: hydrostatic is pressure-driven fluid out, while oncotic is protein/albumin-driven osmotic water shift.
2. Saying lymphatic edema is just “more fluid” without the key point that protein-rich extracellular fluid is not drained back to blood.
3. Explaining dyspné in left-sided heart failure without lungestuvning/stiff lungs and increased lung capillary pressure leading to fluid leakage.
4. Confusing systolic vs diastolic heart failure: systolic is impaired pumping out; diastolic is impaired filling/receiving in the left ventricle.
5. Forgetting that ACE inhibitors reduce angiotensin II and thereby aldosterone production, leading to less sodium/water retention and reduced cardiac workload.
6. In KOLS, attributing emphysema to mucus/inflammation (that’s mainly chronic bronchitis); emphysema is alveolar wall destruction with reduced elastic recoil and impaired gas exchange.
7. Forgetting that Type A adverse effects are dose-related and predictable from the drug’s mechanism, and that they can occur in principle if the dose is high enough.

✅ Exam Checklist

1. For edema: describe the disease mechanism for two causes (hydrostatic, inflammatory/allergic, lymphatic, oncotic) with the correct driving factor (pressure, leakage, lymph drainage failure, or low albumin/osmose).
2. For left-sided heart failure: explain symptoms by linking left ventricle failure to lungestuvning, stiff lungs/dyspné, possible lung edema with pink froth, and dependent hydrostatic edema via RAAS (aldosterone/ADH).
3. For ACE inhibitors: state the mechanism (inhibit ACE → less angiotensin II) and the effect chain (reduced peripheral resistance/BP, reduced aldosterone → less sodium/water reabsorption, reduced cardiac workload).
4. For non-drug treatment in chronic heart failure: include patient/patient-relative teaching about what heart failure is, how medicines work, monitoring fluid/salt and weight to detect fluid retention and adjust diuretics,
5. For KOLS: explain disease mechanisms for chronic bronchitis (edematous mucosa, increased mucus/slim plugs, inflammation cells, smooth muscle changes, fibrosis, peripheral airway closure) and emphysema (alveolar wall dist
6. For lungeemboli: describe the cause as most often a venous thrombus fragment that travels to pulmonary arteries and blocks a branch depending on embolus size.
7. For lungeemboli treatment: state that medication starts before diagnosis is certain (heparin → DOAK or warfarin), and for larger hemodynamically affecting emboli use thrombolysis (or sometimes thrombectomy).
8. For acute kidney failure: explain mechanisms for prerenal (reduced blood volume/perfusion → reduced GFR), renal (damage in kidney tissue like tubules/glomeruli), and postrenal (urinary obstruction → urine accumulation +↑
9. For chronic kidney failure: describe mechanisms, findings, and symptoms for (A) impaired waste excretion (uremic toxins like creatinine/carbamide → fatigue, nausea, itching) and (B) metabolic acidosis (↓H+ excretion/↓HCO
10. For diabetes mellitus type 1: explain the autoimmune mechanism (immune system attacks insulin-producing beta cells in pancreas; inflammation destroys them over years; diabetes after 80–90% destruction).
11. For insulin: state why it must be given parenterally (breakdown in GI tract; oral bioavailability ~0).
12. For insulin action: explain effects on muscle/fat (↑glucose uptake and glycogen storage), liver (↓glucose production via inhibiting glycogenolysis and gluconeogenesis), and fat metabolism (↓free fatty acid release; ↑fat/